Skip to content
  • Facebook
  • Twitter
This translation is automatically provided by Google; please refer to the original English version for appropriate wording.
Take on Typhoid

Take on Typhoid

  • Home
  • Why Typhoid?
    • Typhoid & Related Salmonelloses
    • Global Research
    • Links & Resources
  • The Issues
    • Vaccines
    • WASH
    • Drug-Resistant Typhoid
    • Treatment
    • Diagnostics
    • Typhoid intestinal perforation
    • Related Issues
  • Resources & Tools
    • Talk About Typhoid
    • Global Policy
    • Country Tools
    • Infographics
    • Fact Sheets
    • TCV Cost-effectiveness
    • Share on Social
  • Blog & News
    • Blog
    • News
    • Publications
    • Newsletter
  • International Conference
    • Past Conferences
    • Conference Travel
  • About Us
    • About the Coalition against Typhoid
    • About the Typhoid Vaccine Acceleration Consortium

Typhoid Conjugate Vaccines 11

Posted on December 2, 2021 by admin

A recent modeling analysis shows that TCV is likely cost-effective in countries with high typhoid incidence, high cost of typhoid treatment, and/or high death rates from typhoid.

Post navigation

Typhoid Conjugate Vaccines 10
Typhoid Conjugate Vaccines 12

Newsletter Signup

Recent Posts

  • WASH and vaccines work together to fight disease

  • Three things to know about typhoid and drug resistance

  • Humanly possible: The people making vaccine introductions a reality

  • L’humain au cœur de l’introduction des vaccins

  • Data collection in Cambodia: Ensuring high-quality data to support decision-making

cat
685 West Baltimore Street, Room 480
Baltimore, MD 21201-1509
Coalition against Typhoid
2000 Pennsylvania Ave, NW, Suite 7000
Washington, DC 20006
© 2018. Coalition Against Typhoid. All Rights Reserved.
  • Contact Us
  • Privacy Policy
  • Facebook
  • Twitter
Top